Product Images Xopenex

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Xopenex NDC 21695-153 by Rebel Distributors Corp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structure - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 01

Structure - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 01

Figure 1 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 02

Figure 1 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 02

The text represents a chart or a graph showing the mean change in FEV, which is an abbreviation of Forced Expiratory Volume, measured in percentage (%), against time (hours). The data points for each treatment are represented by different symbols - a circle (o), a square (e), a triangle (a), and a horizontal line (-) for Lev 1.25, Lev 0.63, Rac2.5, and PBO (placebo) treatments, respectively. The sample size (n) for each treatment is also provided. The chart shows that all treatments resulted in a 15% increase in FEV at the end of the study, which lasted for 8 hours.*

Figure 2 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 03

Figure 2 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 03

This is a chart showing the mean change in FEV (Forced Expiratory Volume) in percentage for four different treatments: Lev 1.25, Lev 0.63, Rac2.5, and PBO (Placebo). The chart also displays the number of participants (n) for each treatment. The x-axis represents time in hours, and the y-axis represents the percentage change in FEV. The chart shows that Lev 1.25 had the highest mean change in FEV followed by Lev 0.63, Rac2.5, and PBO. The chart is incomplete as it only shows data for the first three hours, with a mean change of 15%.*

Figure 3 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 04

Figure 3 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 04

Figure 4 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 05

Figure 4 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 05

Figure 1 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 06

Figure 1 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 06

Figure 2 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 07

Figure 2 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 07

Figure 3 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 08

Figure 3 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 08

Figure 4 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 09

Figure 4 - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 09

Xopenex 1.25mg/3ml - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 10

Xopenex 1.25mg/3ml - 35eb525b 72a5 4ef9 a36a 531e9e6b3560 10

This is a product label for Xopenex, which comes in the form of 2 unit-dose vials containing 1.26mg/3ml medication. The product has a National Drug Code (NDC) of 21695-153-24 and a product ID of RX015324. The rest of the text is not-readable due to errors.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.